Showing results (2791-2800 of 4,129) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.Human Gene Therapy|August 19, 2007
Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimuriumCan Xie, Jin-Sheng He, Mei Zhang, et al.Human Gene Therapy|June 19, 2007
A cancer cell-specific inducer of apoptosisKatie L Green, Craig Brown, Geraldine E Roeder, et al.Human Gene Therapy|August 30, 2007
E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effectsJaesung Kim, Joo-Hang Kim, Kyung-Ju Choi, et al.Human Gene Therapy|June 15, 2007
In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculatureSerena Zacchigna, Ennio Tasciotti, Claudia Kusmic, et al.Human Gene Therapy|May 24, 2007
Human immunodeficiency viral vector pseudotyped with the spike envelope of severe acute respiratory syndrome coronavirus transduces human airway epithelial cells and dendritic cellsGary P Kobinger, Maria P Limberis, Suri Somanathan, et al.Human Gene Therapy|September 5, 2007
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscleV Arechavala-Gomeza, I R Graham, L J Popplewell, et al.Human Gene Therapy|September 13, 2008
Improved splicing of adeno-associated viral (AAV) capsid protein-supplying pre-mRNAs leads to increased recombinant AAV vector productionK David Farris, David J PintelHuman Gene Therapy|September 10, 2008
Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responsesEric A Weaver, Michael A BarryPageof 413